Canada - English - Health Canada

hoffmann-la roche limited - vemurafenib - tablet - 240mg - vemurafenib 240mg - antineoplastic agents

Canada - English - Health Canada

mesoblast international sarl - remestemcel-l - solution - 100000000unit - remestemcel-l 100000000unit - unassigned

Canada - English - Health Canada

novartis pharmaceuticals canada inc - dabrafenib (dabrafenib mesylate) - capsule - 50mg - dabrafenib (dabrafenib mesylate) 50mg - antineoplastic agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - dabrafenib (dabrafenib mesylate) - capsule - 75mg - dabrafenib (dabrafenib mesylate) 75mg - antineoplastic agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - trametinib - tablet - 0.5mg - trametinib 0.5mg - antineoplastic agents

Canada - English - Health Canada

novartis pharmaceuticals canada inc - trametinib - tablet - 2mg - trametinib 2mg - antineoplastic agents

United States - English - NLM (National Library of Medicine)

acella pharmaceuticals - urea (unii: 8w8t17847w) (urea - unii:8w8t17847w) - urea 50 g in 100 g - indications and usage: for debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis palmaris, keratoderma, corns and calluses. contraindications: known hypersensitivity to any of the listed ingredients.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - acitretin - oral capsule - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - acitretin - oral capsule - 25mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - acitretin - oral capsule - 10mg